A Study of Polatuzumab Vedotin, Rituximab and Dose Attenuated CHP in Older Patients With DLBCL
Clinical trial NCT04594798 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04594798
- Sponsor
- University of Rochester
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-20
- Primary completion
- 2026-07-31
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.